# Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease

> **NCT07372781** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Beijing Chest Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Monotherapy
- Mycobacterium Abscessus Infection

## Interventions

- **DRUG:** Contezolid
- **DRUG:** linezolid

## Key facts

- **NCT ID:** NCT07372781
- **Lead sponsor:** Beijing Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07372781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07372781, "Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07372781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*